Final Rule Clarifies Liability for Off-Label Uses and Lab’s Right to Create LDTs by Glenn S. Demby | Sep 13, 2021 | Articles, Essential, FDA-lir, Laboratory Industry Report, LDTs-lir... This content is for Paid Members only.Login Register
Agency Imposes 2.5 Percent Increase in 2022 Premarket Application User Fees by Glenn S. Demby | Sep 6, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.Login Register
FDA Regulation of COVID-19 Testing Enters a New Phase by Glenn S. Demby | Aug 26, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.Login Register
FDA Hikes Premarket Application User Fees by 2.5 Percent by Glenn S. Demby | Aug 26, 2021 | Articles, Essential, FDA-nir, Fee Schedules-nir, National Lab Reporter... This content is for Paid Members only.Login Register
FDA Watch: VALID and VITAL Bills for LDTs Regulation Are Back in Play by Glenn S. Demby | Aug 17, 2021 | Articles, Essential, FDA-lir, Laboratory Industry Report... This content is for Paid Members only.Login Register